147 related articles for article (PubMed ID: 7514435)
1. Ovarian and extragonadal malignant germ-cell tumors in females: a single-institution experience with 43 patients.
Mayordomo JI; Paz-Ares L; Rivera F; López-Brea M; López Martín E; Mendiola C; Díaz-Puente MT; Lianes P; García-Prats MD; Cortés-Funes H
Ann Oncol; 1994 Mar; 5(3):225-31. PubMed ID: 7514435
[TBL] [Abstract][Full Text] [Related]
2. Residual tumor after the salvage surgery is the major risk factors for primary treatment failure in malignant ovarian germ cell tumors: a retrospective study of single institution.
Lee CW; Song MJ; Park ST; Ki EY; Lee SJ; Lee KH; Ryu KS; Park JS; Hur SY
World J Surg Oncol; 2011 Oct; 9():123. PubMed ID: 21988930
[TBL] [Abstract][Full Text] [Related]
3. Conservative surgical management of malignant ovarian germ cell tumors: the experience of the Gynecologic Oncology Unit at Ain Shams University.
El-Lamie IK; Shehata NA; Abou-Loz SK; El-Lamie KI
Eur J Gynaecol Oncol; 2000; 21(6):605-9. PubMed ID: 11214621
[TBL] [Abstract][Full Text] [Related]
4. Malignant ovarian germ cell tumors in pediatric patients: The AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) study.
Terenziani M; Bisogno G; Boldrini R; Cecchetto G; Conte M; Boschetti L; De Pasquale MD; Biasoni D; Inserra A; Siracusa F; Basso ME; De Leonardis F; Di Pinto D; Barretta F; Spreafico F; D'Angelo P
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28449306
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors and role of salvage surgery in chemorefractory ovarian germ cell malignancies: a study in Chinese patients.
Li J; Yang W; Wu X
Gynecol Oncol; 2007 Jun; 105(3):769-75. PubMed ID: 17459461
[TBL] [Abstract][Full Text] [Related]
6. A phase II study of high-dose cisplatin, vinblastine, bleomycin, and etoposide (PVeBV regimen) in malignant nondysgerminomatous germ-cell tumors of the ovary.
Culine S; Kattan J; Lhomme C; Duvillard P; Michel G; Castaigne D; Leclere J; Pico J; Droz JP
Gynecol Oncol; 1994 Jul; 54(1):47-53. PubMed ID: 7517380
[TBL] [Abstract][Full Text] [Related]
7. Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin.
Gershenson DM; Morris M; Cangir A; Kavanagh JJ; Stringer CA; Edwards CL; Silva EG; Wharton JT
J Clin Oncol; 1990 Apr; 8(4):715-20. PubMed ID: 1690272
[TBL] [Abstract][Full Text] [Related]
8. Outcome and staging evaluation in malignant germ cell tumors of the ovary in children and adolescents: an intergroup study.
Billmire D; Vinocur C; Rescorla F; Cushing B; London W; Schlatter M; Davis M; Giller R; Lauer S; Olson T;
J Pediatr Surg; 2004 Mar; 39(3):424-9; discussion 424-9. PubMed ID: 15017564
[TBL] [Abstract][Full Text] [Related]
9. Favorable outcome of ovarian germ cell malignancies treated with cisplatin or carboplatin-based chemotherapy: a Hellenic Cooperative Oncology Group study.
Dimopoulos MA; Papadopoulou M; Andreopoulou E; Papadimitriou C; Pavlidis N; Aravantinos G; Aspropotamitis A; Anagnostopoulos A; Fountzilas G; Michalas S; Pectacides D
Gynecol Oncol; 1998 Jul; 70(1):70-4. PubMed ID: 9698477
[TBL] [Abstract][Full Text] [Related]
10. Yolk sac tumours of the ovary: evaluation of clinicopathological features and prognostic factors.
Cicin I; Saip P; Guney N; Eralp Y; Ayan I; Kebudi R; Topuz E
Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):210-4. PubMed ID: 19419810
[TBL] [Abstract][Full Text] [Related]
11. Current management of malignant germ cell tumor of the ovary.
Aziz MF
Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():262-76. PubMed ID: 7661594
[TBL] [Abstract][Full Text] [Related]
12. [BEP/VIP in children and adolescents with malignant non-testicular germ cell tumors. A comparison of the results of treatment of therapy studies MAKEI 83/86 and 89P/89].
Göbel U; Calaminus G; Teske C; Bamberg M; Bökkerink JP; Haas RJ; Holschneider AM; Janka-Schaub G; Jürgens H; Mittler U
Klin Padiatr; 1993; 205(4):231-40. PubMed ID: 7690864
[TBL] [Abstract][Full Text] [Related]
13. Management of early ovarian cancer: germ cell and sex cord-stromal tumors.
Gershenson DM
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S62-72. PubMed ID: 7530680
[TBL] [Abstract][Full Text] [Related]
14. Malignant ovarian germ cell tumors.
Chow SN; Yang JH; Lin YH; Chen YP; Lai JI; Chen RJ; Chen CD
Int J Gynaecol Obstet; 1996 May; 53(2):151-8. PubMed ID: 8735296
[TBL] [Abstract][Full Text] [Related]
15. Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary.
Tangir J; Zelterman D; Ma W; Schwartz PE
Obstet Gynecol; 2003 Feb; 101(2):251-7. PubMed ID: 12576247
[TBL] [Abstract][Full Text] [Related]
16. [Non-testicular germ cell tumors: analysis of the therapy study MAKEI 83/86 anc changes in the protocol for the follow-up study].
Göbel U; Bamberg M; Haas RJ; Bökkerink JP; Brämswig G; Calaminus G; Engert J; Gadner H; Havers W; Janka-Schaub GE
Klin Padiatr; 1989; 201(4):247-60. PubMed ID: 2476583
[TBL] [Abstract][Full Text] [Related]
17. Results of the United Kingdom Children's Cancer Study Group's malignant germ cell tumor studies.
Mann JR; Pearson D; Barrett A; Raafat F; Barnes JM; Wallendszus KR
Cancer; 1989 May; 63(9):1657-67. PubMed ID: 2467734
[TBL] [Abstract][Full Text] [Related]
18. Recent management of malignant ovarian germ cell tumors: a study of 34 cases.
Linasmita V; Srisupundit S; Wilailak S; Tangtrakul S; Israngura N; Bullangpoti S
J Obstet Gynaecol Res; 1999 Oct; 25(5):315-20. PubMed ID: 10533325
[TBL] [Abstract][Full Text] [Related]
19. Malignant ovarian tumors in children: 22 years of experience at a single institution.
Akyüz C; Varan A; Büyükpamukçu N; Kutluk T; Büyükpamukçu M
J Pediatr Hematol Oncol; 2000; 22(5):422-7. PubMed ID: 11037853
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of non-testicular germ cell tumors in children and adolescents with BEP and VIP: initial results of the MAKEI 89 therapy study].
Göbel U; Bamberg M; Engert J; Gnekow AK; Haas HJ; Jürgens H; Kühl J; Lenard HG; Lumenta C; Niethammer D
Klin Padiatr; 1991; 203(4):236-45. PubMed ID: 1719267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]